CONDITION
Glioma in Dogs
A glioma is a tumour that arises from the supporting cells inside the brain itself — the glial cells that surround and insulate nerve tissue. These tumours grow within the substance of the brain, rather than on its surface or in surrounding structures, and their behaviour varies: some are low-grade and slow-growing, but the most common form in dogs is high-grade and progresses more rapidly. Owners often arrive on this page because their dog has developed changes in behaviour, coordination, or awareness that have persisted or worsened — perhaps seizures that have begun in an older dog, a head tilt or circling that does not resolve, or subtle shifts in personality or responsiveness. These signs reflect disruption to specific regions of the brain, and the pattern depends on where the tumour is located and how quickly it is expanding. This page explores what those early signals can look like, what is happening beneath them, how gliomas are investigated using imaging and sometimes biopsy, and what approaches exist — from monitoring and supportive care to surgery, radiation, and chemotherapy. The aim is to help you understand the landscape, not to prescribe a path.
Why this matters now
Gliomas tend to appear in middle-aged to older dogs, most commonly between six and ten years of age, though younger animals can occasionally be affected. Certain breeds — including Boxers, Boston Terriers, Bulldogs, and other brachycephalic types — appear over-represented in case series, though gliomas can arise in any breed or cross. There is no established link to diet, environment, or lifestyle; the tumours develop from cells that have been present since early brain development.
The pace of change varies with tumour grade and location. Low-grade gliomas may grow slowly over months, producing subtle shifts in behaviour or mild neurological signs that owners notice only in hindsight. High-grade tumours, which are more common in dogs, tend to progress over weeks to a few months, with signs often worsening in a stepwise or accelerating pattern as the mass expands and surrounding tissue swells. Individual variation is wide; some dogs plateau for a time before deteriorating, while others show steady decline from the point of first recognition.
Signals & patterns
Early signals
New-onset seizures in an older dog
Seizures that begin for the first time in a dog over five years of age can reflect structural brain disease, and a glioma is one possible cause. The seizures may be focal, affecting one side of the body, or generalised, and their frequency can vary widely in the early weeks.
Subtle personality or behaviour shifts
Owners sometimes describe their dog as "not quite themselves" — quieter, less responsive to familiar cues, or seeming confused in familiar spaces. These changes can be easy to dismiss as ageing, but when they persist or progress, they may reflect disruption to the frontal or temporal lobes.
Head tilt or circling
A persistent lean to one side, circling in one direction, or holding the head at an angle can indicate pressure or damage to structures involved in balance and spatial orientation. These signs often reflect involvement of deeper brain regions near the brainstem or cerebellum.
Coordination difficulties
Stumbling, misjudging jumps, or scuffing the paws on one side may appear gradually. These motor changes suggest involvement of pathways that coordinate voluntary movement, and they can be subtle at first before becoming more obvious.
Vision changes in one or both eyes
A dog may begin to bump into objects on one side, or fail to track movement they would normally notice. This can reflect disruption to the optic pathways or visual processing centres in the occipital cortex, even when the eyes themselves appear normal.
Later signals
Frequent or prolonged seizures
As the tumour grows, seizures often increase in frequency or duration, and they may become harder to manage with medication. Clusters of seizures within a short period, or seizures that last longer than a few minutes, represent escalation of the underlying disruption.
Loss of learned behaviours
Dogs may stop responding to their name, forget house-training, or lose the ability to navigate familiar layouts. This reflects more widespread damage to cortical areas involved in memory, learning, and executive function.
Weakness or paralysis on one side
Progressive weakness affecting the limbs on one side of the body, or inability to stand or walk, can develop as the tumour compresses or invades motor pathways. The degree of impairment depends on the extent and location of tissue involvement.
Altered consciousness or responsiveness
Drowsiness, difficulty waking, or a blank, unresponsive stare can emerge as swelling increases or the tumour affects brainstem structures that regulate arousal. These changes represent more profound disruption to normal brain function.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a detailed history and neurological examination to identify which part of the brain may be affected. Blood tests and imaging of other body systems help rule out conditions that can mimic brain tumours, such as metabolic disease or infections. When a brain mass is suspected, advanced imaging — usually magnetic resonance imaging — is used to visualise the tumour's location, size, and characteristics, and occasionally a tissue sample is obtained to confirm the diagnosis.
Physical examination
Chemistry panel
Complete blood count
Magnetic resonance imaging (MRI)
Histopathology
Options & trade-offs
Management of a glioma usually involves a combination of approaches tailored to the individual dog, the tumour's location and grade, and what the household can sustain. Some owners focus on comfort and quality of time; others pursue treatment aimed at slowing progression or reducing the mass. No single path suits every situation, and the landscape shifts as the tumour evolves.
Supportive care and monitoring
This approach prioritises symptom management without attempting to slow the tumour itself. Anti-seizure medication controls fits when present, corticosteroids reduce brain swelling and can improve neurological signs temporarily, and pain relief addresses discomfort. The focus is on preserving quality of life for as long as the dog remains comfortable and engaged.
Trade-offs: Corticosteroids often produce temporary improvement, but their effect wanes as the tumour grows, and long-term use brings side effects including increased thirst, hunger, and risk of infection. This approach does not alter the tumour's trajectory, and neurological decline typically continues over weeks to months.
Surgical resection
Surgery aims to remove as much of the tumour as possible, reducing mass effect and pressure within the skull. In dogs with accessible, well-demarcated low-grade tumours, resection can produce meaningful improvement and extend good-quality time. High-grade gliomas infiltrate surrounding tissue and cannot usually be completely removed, but partial resection (debulking) may still relieve pressure and improve neurological function temporarily.
Trade-offs: Brain surgery carries significant procedural risk, including bleeding, infection, worsening neurological deficits, and anaesthetic complications. Recovery can be prolonged, and even when surgery goes well, high-grade tumours often regrow within months. Access to neurosurgical expertise is limited and cost is substantial.
Radiation therapy
External beam radiation targets the tumour and surrounding margin, aiming to slow cell division and shrink the mass. It is often used after surgery to address residual disease, or as a primary treatment when surgery is not feasible. Protocols typically involve multiple sessions over several weeks under short anaesthesia.
Trade-offs: Radiation requires access to specialist centres, repeated travel, and general anaesthesia for each fraction. It can slow progression and improve signs in many dogs, but does not cure high-grade gliomas; eventual regrowth is common. Late effects, such as damage to normal brain tissue, can appear months after treatment.
Chemotherapy
Certain chemotherapy drugs, most commonly temozolomide or lomustine, can cross the blood-brain barrier and are used to slow tumour growth, often in combination with surgery or radiation. Treatment is given orally at home in cycles, with periodic monitoring of blood counts and liver function.
Trade-offs: The blood-brain barrier limits drug penetration, and high-grade gliomas in dogs often show limited response. Side effects can include nausea, bone marrow suppression, and liver toxicity, requiring dose adjustment or discontinuation. Chemotherapy may extend survival modestly when combined with other treatments, but evidence for benefit as a sole therapy is limited.
Palliative and end-of-life planning
This approach acknowledges that curative treatment is not the goal and focuses on comfort, dignity, and clarity about when quality of life has declined beyond an acceptable threshold. It may involve low-dose corticosteroids, anti-seizure medication, and open conversation with a vet about what changes would signal that the time has come.
Trade-offs: It requires owners to observe closely and make decisions in ambiguity, often without clear markers of distress. Some dogs plateau for weeks and remain comfortable; others deteriorate quickly, and recognising that shift can be difficult.
Common misconceptions
"A brain tumour diagnosis always means the dog has only days or weeks left."
Prognosis varies widely depending on tumour type, grade, location, and whether treatment is pursued. Low-grade gliomas can sometimes be managed for many months, and even high-grade tumours treated with surgery and radiation can offer several months of good quality time. Without treatment, decline tends to occur over weeks to a few months, but individual variation is wide.
"If the dog is still eating and wagging its tail, the tumour cannot be progressing."
Many dogs with brain tumours retain appetite and elements of normal behaviour even as neurological function deteriorates. Personality changes, subtle gait abnormalities, or intermittent confusion can be present alongside apparently normal interactions. Appetite and affection are important but do not on their own reflect the tumour's activity or the dog's internal experience.
"Steroids will cure the problem or stop the tumour growing."
Corticosteroids reduce swelling around the tumour and can produce rapid, sometimes dramatic improvement in neurological signs, but they do not affect the tumour cells themselves. The benefit is temporary, often lasting weeks to a few months, and signs typically return as the tumour continues to expand despite ongoing steroid use.
Related conditions
Brain Tumours
Brain tumours is the broader category under which gliomas sit; gliomas arise from within the substance of the brain itself, whereas other brain tumours may originate from the membranes surrounding it, the pituitary gland, or sites elsewhere in the body that have spread to the brain.
Epilepsy in Dogs
Seizures are often an early or prominent sign in dogs with glioma, particularly when the tumour affects the cerebral cortex; epilepsy in dogs describes recurrent seizures from various causes, and distinguishing seizures due to a structural brain lesion from idiopathic epilepsy typically requires imaging.
Canine Cognitive Dysfunction
Cognitive dysfunction and glioma can both cause changes in behaviour, responsiveness, or spatial awareness in older dogs; in cognitive dysfunction the decline tends to be gradual and diffuse, whereas glioma often produces more focal or progressive neurological signs that may prompt earlier investigation.
Chemodectoma (Heart Base Tumour)
Chemodectomas and gliomas are both tumours that tend to occur in middle-aged to older dogs and may require similar approaches to investigation—advanced imaging, consideration of biopsy, and shared conversations about surgery, radiation, and quality of life—though they arise in entirely different locations and affect different body systems.
Acromegaly in Cats
Acromegaly in cats is caused by a pituitary tumour that can sometimes produce neurological signs through local mass effect, similar to the way a glioma exerts pressure within the brain; both conditions illustrate how growths inside the skull can disrupt normal function through their physical presence, regardless of whether they are benign or malignant.
If imaging has confirmed or strongly suggested a glioma, the next layer often involves weighing which combination of approaches feels workable — not just medically, but practically and emotionally. Questions about what constitutes acceptable quality of life, how to recognise meaningful decline, and what support exists at different stages are all useful territory to explore. Other pages in the Longevity & Healthspan pillar discuss related neurological conditions, seizure management, and the broader context of ageing in dogs.